Supplemental Guarantor Information (Tables)

9 Months Ended

Oct. 02, 2011

Supplemental Guarantor Information [Abstract]

Supplemental Condensed Consolidating Balance Sheets

Supplemental Condensed Consolidating Balance Sheets

	October 2, 2011
	Issuer			Non- Guarantor Subsidiaries		Eliminations			Total
	(Unaudited) (In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	72,858		$	275,332	$	—		$	348,190
Receivables, net		141,702			207,545		—			349,247
Inventories, net		108,578			88,522		—			197,100
Deferred income taxes		7,745			1,914		—			9,659
Other current assets		9,773			12,074		—			21,847
Total current assets		340,656			585,387		—			926,043
Property, plant and equipment, less accumulated depreciation		124,694			159,298		—			283,992
Goodwill		220,842			132,005		—			352,847
Intangible assets, less accumulated amortization		66,582			89,814		—			156,396
Deferred income taxes		7,249			13,748		—			20,997
Other long-lived assets		13,863			56,514		—			70,377
Investment in subsidiaries		1,303,682			—		(1,303,682	)		—
	$	2,077,568		$	1,036,766	$	(1,303,682	)	$	1,810,652
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	98,804		$	135,185	$	—		$	233,989
Accrued liabilities		77,265			89,264		—			166,529
Total current liabilities		176,069			224,449		—			400,518
Long-term debt		550,955			—		—			550,955
Postretirement benefits		30,670			86,256		—			116,926
Other long-term liabilities		22,227			10,312		—			32,539
Intercompany accounts		(39,565	)		39,565		—			—
Total stockholders’ equity		1,337,212			676,184		(1,303,682	)		709,714
	$	2,077,568		$	1,036,766	$	(1,303,682	)	$	1,810,652

	December 31, 2010
	Issuer			Non- Guarantor Subsidiaries		Eliminations			Total
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	173,699		$	184,954	$	—		$	358,653
Receivables, net		117,303			180,963		—			298,266
Inventories, net		109,127			66,532		—			175,659
Deferred income taxes		5,590			3,883		—			9,473
Other current assets		10,199			8,605		—			18,804
Total current assets		415,918			444,937		—			860,855
Property, plant and equipment, less accumulated depreciation		120,857			158,009		—			278,866
Goodwill		258,094			64,462		—			322,556
Intangible assets, less accumulated amortization		93,695			50,125		—			143,820
Deferred income taxes		9,342			18,223		—			27,565
Other long-lived assets		12,771			50,051		—			62,822
Investment in subsidiaries		1,227,959			—		(1,227,959)			—
	$	2,138,636		$	785,807	$	(1,227,959	)	$	1,696,484
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	92,996		$	119,088	$	—		$	212,084
Accrued liabilities		78,013			67,827		—			145,840
Total current liabilities		171,009			186,915		—			357,924
Long-term debt		551,155			—		—			551,155
Postretirement benefits		27,949			84,477		—			112,426
Other long-term liabilities		30,047			6,417		—			36,464
Intercompany accounts		(249,051	)		249,051		—			—
Total stockholders’ equity		1,607,527			258,947		(1,227,959	)		638,515
	$	2,138,636		$	785,807	$	(1,227,959	)	$	1,696,484

Supplemental Condensed Consolidating Statements of Operations

Supplemental Condensed Consolidating Statements of Operations (Unaudited)

	Three Months Ended October 2, 2011
	Issuer			Non- Guarantor Subsidiaries			Eliminations			Total
	(In thousands)
Revenues	$	270,679		$	316,087		$	(67,053	)	$	519,713
Cost of sales		(207,466	)		(226,549	)		67,053			(366,962	)
Gross profit		63,213			89,538			—			152,751
Selling, general and administrative expenses		(46,932	)		(38,423	)		—			(85,355	)
Research and development		(2,486	)		(11,155	)		—			(13,641	)
Amortization of intangibles		(820	)		(2,551	)		—			(3,371	)
Income from equity method investment		—			1,479			—			1,479
Operating income		12,975			38,888			—			51,863
Interest expense		(11,662	)		(28	)		—			(11,690	)
Interest income		12			199			—			211
Intercompany income (expense)		9,622			(9,622	)		—			—
Income (loss) from equity investment in subsidiaries		22,936			—			(22,936	)		—
Income (loss) from continuing operations before taxes		33,883			29,437			(22,936	)		40,384
Income tax expense		(2,518	)		(6,501	)		—			(9,019	)
Income (loss) from continuing operations		31,365			22,936			(22,936	)		31,365
Loss from discontinued operations, net of tax		(162	)		—			—			(162	)
Net income (loss)	$	31,203		$	22,936		$	(22,936	)	$	31,203

	Three Months Ended October 3, 2010
	Issuer			Non- Guarantor Subsidiaries			Eliminations			Total
	(In thousands)
Revenues	$	242,794		$	193,624		$	(39,491	)	$	396,927
Cost of sales		(168,201	)		(150,033	)		39,491			(278,743	)
Gross profit		74,593			43,591			—			118,184
Selling, general and administrative expenses		(42,272	)		(23,892	)		—			(66,164	)
Research and development		(3,315	)		(7,572	)		—			(10,887	)
Amortization of intangibles		(727	)		(1,873	)		—			(2,600	)
Income from equity method investment		—			3,053			—			3,053
Operating income		28,279			13,307			—			41,586
Interest expense		(11,451	)		(327	)		—			(11,778	)
Interest income		45			35			—			80
Intercompany income (expense)		(514	)		514			—			—
Income (loss) from equity investment in subsidiaries		10,658			—			(10,658	)		—
Income (loss) from continuing operations before taxes		27,017			13,529			(10,658	)		29,888
Income tax expense		(4,373	)		(2,871	)		—			(7,244	)
Income (loss) from continuing operations		22,644			10,658			(10,658	)		22,644
Loss from discontinued operations, net of tax		(2,039	)		—			—			(2,039	)
Net income (loss)	$	20,605		$	10,658		$	(10,658	)	$	20,605

	Nine Months Ended October 2, 2011
	Issuer			Non- Guarantor Subsidiaries			Eliminations			Total
	(In thousands)
Revenues	$	792,028		$	887,652		$	(162,088	)	$	1,517,592
Cost of sales		(596,368	)		(643,492	)		162,088			(1,077,772	)
Gross profit		195,660			244,160			—			439,820
Selling, general and administrative expenses		(130,750	)		(113,921	)		—			(244,671	)
Research and development		(8,136	)		(33,664	)		—			(41,800	)
Amortization of intangibles		(2,460	)		(7,937	)		—			(10,397	)
Income from equity method investment		—			9,196			—			9,196
Operating income		54,314			97,834			—			152,148
Interest expense		(35,606	)		(640	)		—			(36,246	)
Interest income		84			442			—			526
Intercompany income (expense)		(5,064	)		5,064			—			—
Income (loss) from equity investment in subsidiaries		78,589			—			(78,589	)		—
Income (loss) from continuing operations before taxes		92,317			102,700			(78,589	)		116,428
Income tax expense		(4,053	)		(24,111	)		—			(28,164	)
Income (loss) from continuing operations		88,264			78,589			(78,589	)		88,264
Loss from discontinued operations, net of tax		(446	)		—			—			(446	)
Net income (loss)	$	87,818		$	78,589		$	(78,589	)	$	87,818

	Nine Months Ended October 3, 2010
	Issuer			Non- Guarantor Subsidiaries			Eliminations			Total
				(In thousands)
Revenues	$	639,496		$	667,123		$	(114,705	)	$	1,191,914
Cost of sales		(452,287	)		(508,434	)		114,705			(846,016	)
Gross profit		187,209			158,689			—			345,898
Selling, general and administrative expenses		(117,205	)		(86,101	)		—			(203,306	)
Research and development		(8,601	)		(22,505	)		—			(31,106	)
Amortization of intangibles		(2,193	)		(5,707	)		—			(7,900	)
Income from equity method investment		—			8,905			—			8,905
Operating income		59,210			53,281			—			112,491
Interest expense		(38,676	)		(234	)		—			(38,910	)
Interest income		124			274			—			398
Other income		—			1,465			—			1,465
Intercompany income (expense)		(820	)		820			—			—
Income (loss) from equity investment in subsidiaries		42,936			—			(42,936	)		—
Income (loss) from continuing operations before taxes		62,774			55,606			(42,936	)		75,444
Income tax expense		(4,215	)		(12,670	)		—			(16,885	)
Income (loss) from continuing operations		58,559			42,936			(42,936	)		58,559
Loss from discontinued operations, net of tax		(6,535	)		—			—			(6,535	)
Net income (loss)	$	52,024		$	42,936		$	(42,936	)	$	52,024

Supplemental Condensed Consolidating Statements of Cash Flows

Supplemental Condensed Consolidating Statements of Cash Flows (Unaudited)

	Nine Months Ended October 2, 2011
	Issuer			Non- Guarantor Subsidiaries			Total
	(In thousands)
Net cash provided by (used for) operating activities	$	(911	)	$	100,373		$	99,462
Cash flows from investing activities:
Cash used to acquire businesses, net of cash acquired		(59,708	)		—			(59,708	)
Capital expenditures		(12,327	)		(9,433	)		(21,760	)
Proceeds from disposal of tangible assets		1,135			71			1,206
Net cash used for investing activities		(70,900	)		(9,362	)		(80,262	)
Cash flows from financing activities:
Payments under share repurchase program		(25,000	)		—			(25,000	)
Cash dividends paid		(7,090	)		—			(7,090	)
Debt issuance costs		(3,296	)		—			(3,296	)
Tax benefit related to share-based compensation		1,802			—			1,802
Proceeds from exercise of stock options		4,554			—			4,554
Net cash used for financing activities		(29,030	)		—			(29,030	)
Effect of currency exchange rate changes on cash and cash equivalents		—			(633	)		(633	)
Increase (decrease) in cash and cash equivalents		(100,841	)		90,378			(10,463	)
Cash and cash equivalents, beginning of period		173,699			184,954			358,653
Cash and cash equivalents, end of period	$	72,858		$	275,332		$	348,190

	Nine Months Ended October 3, 2010
	Issuer			Non- Guarantor Subsidiaries			Total
	(In thousands)
Net cash provided by (used for) operating activities	$	106,459		$	(51,048	)	$	55,411
Cash flows from investing activities:
Capital expenditures		(10,142	)		(9,056	)		(19,198	)
Proceeds from disposal of tangible assets		2,314			18			2,332
Cash provided by other investing activities		163			—			163
Net cash used for investing activities		(7,665	)		(9,038	)		(16,703	)
Cash flows from financing activities:
Payments under borrowing arrangements		(46,268	)		—			(46,268	)
Cash dividends paid		(7,052	)		—			(7,052	)
Tax deficiency related to share-based compensation		(239	)		—			(239	)
Proceeds from exercise of stock options		720			—			720
Cash received upon termination of derivative instruments		4,217			—			4,217
Net cash used for financing activities		(48,622	)		—			(48,622	)
Effect of currency exchange rate changes on cash and cash equivalents		—			(2,884	)		(2,884	)
Increase (decrease) in cash and cash equivalents		50,172			(62,970	)		(12,798	)
Cash and cash equivalents, beginning of period		58,855			250,024			308,879
Cash and cash equivalents, end of period	$	109,027		$	187,054		$	296,081